23 Jul Taysha Gene Therapies
Suyash Prasad, Chief Medical Officer and Head of Research and Development
Oct. 12 | 2:30pm | AVROBIO Ballroom
Dallas, TX
(NASDAQ: TSHA)
In-person Presentation
Taysha Gene Therapies is on a mission to eradicate monogenic central nervous system disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform – an engine for potential new cures – with a goal of dramatically improving patients’ lives.
